There is a good chance the stock will move up but

There is a good chance the stock will move up but not shoot back up unless there is a fund that decides to take a chance and take stake in AMBS. The damage done by whatever hedge fund, Discovery?, that sold like there was no tomorrow will be hard to repair, especially as long as AMBS continues to trade on the OTC. The company's failure to get up listed was a monumental failure by the CEO. How many years has he stated this was "on track" and yet never accomplished? At some point you'd think he'd be held accountable but that doesn't happen with these OTC companies. I have a small stake because it's a risk i am willing to take but the CEO and BOD clearly lost sight of what the main goal was and that was to up list. And remember, there is a biotech grave yard of companies with good science that never saw the light of day due to poor management. Amarantus has one foot in that grave, imo. We'll see if the CEO can, for once, actually execute instead of feeding his investors empty promises.